T-group (topology)
270.1.1 FMT C-terminal domain-related
Ligands and drugs
1,142
Member domains
88
with ligand contacts (≤ 4 Å)
7.7% of members
84
with DrugDomain annotations
7.4% of members
59
with a DrugBank compound
5.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 270.1.1 belongs to X-group 270 FMT C-terminal domain-like, which has 18 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 14 |
| DB03256 | FON | (6R)-Folinic acid | 13 |
| DB03103 | TYD | Thymidine-5'- Diphosphate | 11 |
| DB01992 | COA | Coenzyme A | 8 |
| DB02031 | THG | (6S)-5,6,7,8-tetrahydrofolic acid | 4 |
| DB00116 | — | — | 2 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 2 |
| DB03685 | U5P | Uridine monophosphate | 2 |
| DB03751 | DAU | 2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose | 2 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 2 |
| DB00158 | FOL | Folic acid | 1 |
| DB02078 | PG5 | Triglyme | 1 |
| DB02857 | GMP | Guanosine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 17 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 14 |
| TYD | THYMIDINE-5'-DIPHOSPHATE | 13 |
| 0FX | dTDP-4-amino-4,6-dideoxyglucose | 12 |
| T3F | (3R,4S,5R,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 9 |
| COA | COENZYME A | 8 |
| T3Q | [(3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 8 |
| FON | N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid | 4 |
| G3N | (2R,3R,4S,5S)-5-amino-3,4-dihydroxytetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 4 |
| THG | (6S)-5,6,7,8-TETRAHYDROFOLATE | 3 |
| 1YA | N-{4-[{[(6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}(formyl)amino]benzoyl}-L-glutamic acid | 2 |
| CL | CHLORIDE ION | 2 |
| DAU | 2'DEOXY-THYMIDINE-5'-DIPHOSPHO-ALPHA-D-GLUCOSE | 2 |
| EP1 | 3-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]PROPANE-1-SULFONIC ACID | 2 |
| FNF | (2R,3R,4S,5R,6R)-4-(formylamino)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) | 2 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 2 |
| U5P | URIDINE-5'-MONOPHOSPHATE | 2 |
| UDP | URIDINE-5'-DIPHOSPHATE | 2 |
| 1YF | [(2R,3R,4S,5S,6R)-4-formamido-6-methyl-3,5-bis(oxidanyl)oxan-2-yl] [[(2R,3S,5R)-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate | 1 |
| 1YJ | N-[4-({[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 1 |